Sustained Effects of a Non-glucidic Nutrient Preload on Glucose Tolerance in Type 2 Diabetes
NCT02477761 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7
Last updated 2015-06-23
Summary
The investigators aimed at evaluating the effects of a small non-glucidic nutrient preload on plasma glucose, insulin, C-peptide, glucagon-like peptide-1, and glucose-dependent insulinotropic polypeptide concentrations after the meal consumption and for 300 min after a 75 g glucose ingestion in diet-controlled type 2 diabetic patients.
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Nutrient preload
Ingestion of a small mixed protein and lipid meal 30 minutes before glucose
Sponsors & Collaborators
-
Azienda Ospedaliero, Universitaria Pisana
lead OTHER
Principal Investigators
-
Andrea Natali, Prof · Azienda Ospedaliero, Universitaria Pisana
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-06-30
- Primary Completion
- 2015-09-30
- Completion
- 2015-09-30
Countries
- Italy
Study Locations
More Related Trials
-
GLP-1 and Oxyntomodulin Release in Relation to Diet in Type 2 Diabetes Patients.
NCT04105608 ·Status: COMPLETED ·Phase: NA
-
The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D
NCT03246451 ·Status: COMPLETED ·Phase: NA
-
Meal Tolerance Trial in Pregnant Women Diagnosed With Gestational Diabetes Mellitus.
NCT02225951 ·Status: TERMINATED ·Phase: NA
-
Insulin Sensitivity and Metabolomics During Oral Administration of Glucose and Graded Intravenous Infusion
NCT03223129 ·Status: COMPLETED ·Phase: NA
-
The Role of Glucagon in the Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-glucose Co-transporter-2 Inhibitors
NCT02792400 ·Status: COMPLETED ·Phase: NA
-
The Importance of Meal Composition on Preventing Exercise-induced Hypoglycemia in People With Type 1 Diabetes.
NCT04472962 ·Status: COMPLETED ·Phase: NA
-
Postprandial Blood Glucose Control and Gastric Emptying in Type 1 Diabetes: Pathogenetic Factors and Therapeutic Options
NCT02365740 ·Status: UNKNOWN ·Phase: NA
-
Near Normalisation of BG Improves the Potentiating Effect of GLP-1
NCT00612625 ·Status: COMPLETED ·Phase: NA
-
The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes
NCT00321321 ·Status: COMPLETED ·Phase: PHASE2
-
Individual Determinants of Postprandial Glucose Response in Type 2 Diabetes
NCT06057246 ·Status: RECRUITING ·Phase: NA
-
"Effect of Dipeptidyl Peptidase IV After Diets in näive Type 2 Diabetic Patients"
NCT00881543 ·Status: COMPLETED ·Phase: NA
-
Low Glycemic Index Diet in Patients With Type 1 Diabetes
NCT01184703 ·Status: COMPLETED ·Phase: PHASE3
-
Study TO Prevent Diabetes With Short-term Insulin Glargine Only
NCT01276912 ·Status: UNKNOWN ·Phase: NA
-
A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)
NCT00782418 ·Status: COMPLETED ·Phase: PHASE1
-
Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients
NCT02847403 ·Status: UNKNOWN ·Phase: PHASE3
-
Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes
NCT04449692 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Postprandial Incretin Response in Women With Gestational Diabetes
NCT01274052 ·Status: COMPLETED
-
The Role of Endogenous Glucagon-like Peptide 1 (GLP-1) in Type 2 Diabetes Mellitus (T2DM)
NCT01449019 ·Status: COMPLETED ·Phase: PHASE1
-
Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment
NCT04177303 ·Status: UNKNOWN ·Phase: PHASE3
-
GA 6: The Blood Glucose-lowering Effect of Glucose-dependent Insulinotropic Polypeptide
NCT03845179 ·Status: COMPLETED ·Phase: NA
-
Lifestyle Control of Postprandial Hyperglycemia
NCT02683135 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Main Determinants of Postprandial Glucose Response in Type 1 Diabetes
NCT05936242 ·Status: RECRUITING
-
Effect of Fasting Therapy on Blood Glucose Control and Islet Function in Newly Diagnosed Type 2 Diabetic Patients
NCT02956655 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes
NCT06120556 ·Status: COMPLETED
-
Effect of GIP After a Meal in Patients With Type 2 Diabetes
NCT03702660 ·Status: COMPLETED ·Phase: NA